Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1CNS 1

Conditions

Brain Neoplasms 8Seizures 6Leukemia, Myeloid, Acute 3Glioma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Glioblastoma 2Central Nervous System Neoplasms 2beta-Thalassemia 1Postoperative Seizures After Brain Tumor Surgery 1Pinealoma 1Oligodendroglioma 1Neurofibromatosis 1 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Neoplasm, Residual 1Necrosis 1Myelodysplastic Syndromes 1Meningioma 1Medulloblastoma 1Leukemia, Myelomonocytic, Juvenile 1Influenza, Human 1Hematologic Neoplasms 1Gliosarcoma 1Epilepsy 1Ependymoma 1Chromosome Aberrations 1Chromosome 7, monosomy 1Astrocytoma 1Anemia, Refractory, with Excess of Blasts 1

Interventions

thymoglobulin 1selinexor 1fludarabine 1Rituximab 1Reverse Transcriptase Polymerase Chain Reaction 1Melphalan 1Levetiracetam 1Daunorubicin 1Cytarabine 1Cyclophosphamide 1Busulfan 1Bronchoalveolar Lavage 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Chromosome Aberrations × Levetiracetam × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡